Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
IPCA Laboratories Limited
IPCALABIpca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India. Address: 125, Kandivli Industrial Estate, Mumbai, India, 400067
Analytics
Objectif de Cours de WallStreet
123 725.21 INRRatio C/B
67.5704Rendement du dividende
0.26 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés IPCALAB
Analyse des dividendes IPCALAB
Croissance des dividendes sur 5 ans
300 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
13 %Historique des dividendes IPCALAB
Valorisation des titres IPCALAB
financières IPCALAB
Résultats | 2019 | Dynamique |